ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
-0.40%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,640.255
0.30%
Brent Oil
72.435
-0.02%
Bitcoin
92,744.27
0.84%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. PhaseBio Pharmaceuticals Inc (CE) (PHASQ)

  7. PhaseBio Pharmaceuticals Inc (CE) (PHASQ) News

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PHASQ
DateTimeSourceHeadlineSymbolCompany
30/09/202420:10Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/09/202420:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/09/202420:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/09/202420:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/09/202420:02Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/09/202420:00Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
15/08/202420:03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
15/08/202420:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
12/07/202420:42Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
16/05/202420:32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
16/05/202420:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
29/11/202321:55Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
15/11/202321:17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
03/10/202311:17Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
27/09/202312:52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
25/08/202316:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
25/08/202316:31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/06/202320:21Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
30/05/202320:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202320:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202320:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202320:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
19/05/202320:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
16/05/202320:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
03/04/202320:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
24/03/202312:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202322:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202320:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
14/02/202319:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
23/12/202213:34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:PHASQ

Your Recent History

BOV
R2NG34
Ringcentral
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Gold Trader

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £3655.44 only £1462.17